EQRx Revises Plans To Get Chinese Licensed Drugs To US Market

 
• By Jessica Merrill
U turn
EQRx is changing development plans for two drugs licensed from Chinese partners. • Source: Shutterstock

More from Clinical Trials

More from R&D